XML 50 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1

Interests in subsidiaries

12 Months Ended

Jun. 30, 2018

Text block1 [abstract]

Interests in subsidiaries

Note 34. Interests in subsidiaries

The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policy described in note 2:

				Ownership interest
Name		Principal place of business / Country of incorporation		2018 %		2017 %
Kazia Laboratories Pty Ltd		Australia		100%		100%
Kazia Research Pty Ltd		Australia		100%		100%
Kazia Therapeutics Inc.		United States of America		100%		100%
Glioblast Pty Ltd		Australia		100%		100%

X

- Definition

The disclosure of interests in subsidiaries. [Refer: Subsidiaries [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2017-01-01
-Paragraph 2
-Subparagraph b
-Clause i
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2017-03-01&anchor=para_2_b_i&doctype=Standard
-URIDate 2017-03-09

+ Details

Name:	ifrs-full_DisclosureOfInterestsInSubsidiariesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Text block.

+ References

No definition available.

+ Details

Name:	kzia_TextBlock1Abstract
Namespace Prefix:	kzia_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration